Hamilton Capital LLC purchased a new position in Merck KGaA (OTCMKTS:MKGAF – Free Report) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 6,524 shares of the company’s stock, valued at approximately $838,000.
Other institutional investors have also recently made changes to their positions in the company. Bank of America Corp DE bought a new position in shares of Merck KGaA during the 2nd quarter worth about $3,923,774,000. Legal & General Group Plc bought a new stake in Merck KGaA in the 2nd quarter valued at about $2,425,225,000. Barrow Hanley Mewhinney & Strauss LLC acquired a new position in Merck KGaA during the 2nd quarter worth approximately $942,087,000. Caisse de depot et placement du Quebec bought a new position in Merck KGaA in the second quarter worth approximately $571,582,000. Finally, Canada Pension Plan Investment Board bought a new position in Merck KGaA in the second quarter worth approximately $536,694,000. Institutional investors and hedge funds own 0.10% of the company’s stock.
Merck KGaA Trading Down 3.9%
Shares of Merck KGaA stock opened at $158.15 on Friday. The stock has a market capitalization of $20.44 billion, a PE ratio of 24.14 and a beta of 0.96. Merck KGaA has a 52 week low of $116.68 and a 52 week high of $175.56. The stock has a 50 day moving average price of $163.21 and a two-hundred day moving average price of $148.95. The company has a debt-to-equity ratio of 0.27, a quick ratio of 0.84 and a current ratio of 1.31.
Merck KGaA Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Featured Stories
- Five stocks we like better than Merck KGaA
- Nutanix’s Rally Has a Bigger Story Than Earnings as AMD’s AI Bet Takes Shape
- SEC Probe Puts Wall Street Leverage Risk Back in Focus
- A Bearish-Dollar Options Surge Raises the Stakes for Warsh at Jackson Hole
- Five Below’s Turnaround Is Working—But Has the Stock Run Too Far?
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
